首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1471951

生育服务市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按程序、患者类型、最终用户和地理位置

Fertility Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Procedure, Patient Type, End User, and Geography

出版日期: 2024年03月18日 | 出版商:

The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格

简介目录

根据我们关于「2031 年生育服务市场预测 - COVID-19 影响和全球分析 - 按程序、患者类型、最终用户」的新研究，该市场预计将从 2023 年的 329.9 亿美元增长到 67.12 美元到2031 年将达到10 亿；预计 2023 年至 2031 年复合年增长率为 9.3%。市场成长归因于日益增长的社会和环境因素以及妇科疾病盛行率的增加。体外受精（IVF）过程中不断进步的技术可能为生育服务市场提供成长机会。然而，与生育服务相关的高成本阻碍了高压氧治疗市场的成长。

遗传性疾病和不孕问题的治疗是辅助受孕的生育服务的一部分。胞浆内单一精子注射（ICSI）和体外受精（IVF）等辅助生殖技术（ART）的发展是生育服务市场最重要的发展之一。这些技术使体外受孕胚胎成为可能，增加了健康怀孕的可能性，彻底改变了生殖医学。其他进步包括植入前基因检测、胚胎冷冻保存和卵子冷冻，为寻求生育治疗的夫妇和个人提供了更多选择。

2023年，亚太地区在全球生育服务市场中占据主要份额。几种不孕不育药物的引入和快速分销推动了该地区的市场成长。预计不孕症治疗领域研究活动的增加将在未来几年为区域市场带来新的机会。此外，美国占据北美市场的最大份额。生活方式的改变以及导致男性和女性不孕和妇科疾病的不健康饮食趋势的增加是市场成长的原因。

体外受精 (IVF) 过程中不断进步的技术推动了生育服务市场的成长机会

体外受精技术的最新进展正在改变生育治疗的格局。从基因筛检到胚胎延时成像，再到人工智慧和改进的培养基，这些创新为饱受不孕症的夫妇带来了希望。这些进步代表了改变体外受精领域、提高成功率并改善整体患者体验的尖端技术和工艺。

进阶说明

植入前基因检测 (PGT) PGT 可以对胚胎进行筛检，以在植入前识别遗传异常，透过选择健康的胚胎来增加成功怀孕的机会。

延时胚胎成像使用延时技术连续监测胚胎发育，可以根据生长模式和里程碑来更好地选择胚胎，从而提高体外受精的成功率。

人工智慧 (AI) 和机器学习人工智慧和机器学习分析患者资料和胚胎髮育，以提供个人化治疗建议，优化 IVF 结果。

卵巢组织冷冻保存这项技术可以为接受癌症治疗或其他影响生育能力的医疗手术的女性冷冻和保存含有存活卵子的卵巢组织。

改良的培养基先进的培养基配方为实验室胚胎发育创造了理想的环境，从而提高胚胎品质和体外受精成功率。

卵子冷冻技术玻璃化冷冻是一种快速冷冻方法，提高了卵子冷冻的成功率，为女性保留生育能力提供了更多选择。

单一胚胎移植 (SET) SET 涉及移植精心挑选的单一胚胎，可降低多胎妊娠的风险，在维持高成功率的同时最大限度地减少併发症。

此外，在生育服务市场运营的大公司正在开发新技术来优化体外受精，从而获得竞争优势。 2022 年 10 月，美国医疗设备製造商 Alife Health 推出了 Alife Assist 平台，这是一系列旨在利用数据驱动的见解和人工智慧 (AI) 彻底改变 IVF 的产品。该平台有助于支持 IVF 关键阶段的临床决策并简化生育诊所运作。这个创新平台由 Stim Assist、Embryo Assist 和 Insights 组成，为生殖内分泌学家、胚胎学家和诊所管理人员提供全面支持，以改善胚胎分级、药物剂量和即时性能监控，最终改善患者体验和 IVF 成功率。预计这些进步将为未来的市场成长提供机会。

基于过程的见解

根据程序，生育服务市场分为辅助生殖技术、人工授精和生育手术。辅助生殖技术领域在 2023 年占据最大市场份额。辅助生殖技术市场进一步细分为体外受精和胞浆内单一精子注射。

基于患者类型的见解

生育服务市场根据患者类型分为男性和女性。到 2023 年，女性细分市场将占据更大的市场份额。

基于最终用户的见解

就最终用户而言，生育服务市场分为生育中心、医院和外科诊所等。生育中心细分市场在 2023 年占据最大的市场份额，预计 2023 年至 2031 年复合年增长率最高。

领先企业正在实施扩张、合作、推出新产品和获取新客户群等策略，以挖掘现有的商机。

2022 年 12 月，Care Fertility Group 进入美国和西班牙，扩大了其全球影响力。

2022 年 11 月，麦凯日间专科医院迎来了新的 Virtus 快速内视镜诊所的开幕。

2022 年 10 月，Indira IVF 与 Maven Clinic 合作，这是一家总部位于美国的公司，在基于远距医疗的虚拟诊所的帮助下，专门从事女性和家庭健康。此次合作旨在为印度的 Maven 成员提供 Indira IVF 的高品质临床护理、其他福利以及透过 Maven 平台提供的最佳虚拟家庭教育护理。 Indira IVF 是一家总部位于印度的连锁专科不孕症诊所。

2022 年 8 月，Genea Fertility 成为澳洲犹太生育网络 (AJFN) 年度大型募款活动的白金赞助商。

美国食品药物管理局、疾病管制与预防中心 (CDC) 和全球疾病负担研究是准备生育服务市场报告时参考的主要和次要来源。

欧洲
- 德国
- 法国
- 义大利
- 西班牙
- 英国
- 欧洲其他地区
亚太
- 澳洲
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区
南美洲和中美洲
- 巴西
- 阿根廷
- 南美洲和中美洲其他地区

第 11 章：产业格局

併购
协议、合作、合资企业
新产品发布
扩张和其他策略发展

第 12 章：竞争格局

关键参与者的热图分析
公司定位与专注

第 13 章：生育服务市场 - 主要公司概况

CooperSurgical, Inc
Vitrolife
Cook Medical
Care Fertility
INVO Bioscience
Carolinas Fertility Institute
Genea Limited
Merck KGaA
LABOTECT GmbH
Monash IVF Group Limited

第 14 章：附录

简介目录

Product Code: TIPRE00004739

According to our new research study on "Fertility Services Market Forecast to 2031 - COVID-19 Impact and Global Analysis - by Procedure, Patient Type, End User," the market is anticipated to grow from US$ 32.99 billion in 2023 to US$ 67.12 billion by 2031; it is estimated to register a CAGR of 9.3% during 2023-2031. Market growth is attributed to the growing social and environmental factors and increasing prevalence of gynecological conditions. Growing technological advancements in in-vitro fertilization (IVF) process are likely to provide growth opportunities for the fertility services market. However, high costs associated with fertility services hinder the growth of the hyperbaric oxygen therapy market.

Treatments for genetic disorders and infertility problems are part of fertility services to aid conception. The development of assisted reproductive technologies (ART) such as intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF), is one of the most significant developments in the fertility services market. These techniques have revolutionized reproductive medicine by making conceiving an embryo outside the body possible, thereby increasing the likelihood of a healthy pregnancy. Other advances include pre-implantation genetic testing, embryo cryopreservation, and egg freezing, providing additional options for couples and individuals pursuing fertility treatments.

Asia Pacific accounted for a major share of the global fertility services market in 2023. The Asia Pacific fertility services market is segmented into the China, Japan, India, South Korea, Australia, rest of Asia Pacific. The introduction and rapid distribution of several infertility drugs drive the market growth in this region. Increasing research activities in infertility treatments are predicted to open up new opportunities for the regional market in the coming years. Furthermore, the US held the largest share of the North American market. Changing lifestyles with increasing trends of unhealthy diets leading to infertility and gynecological disorders in men and women are responsible for the market growth.

Growing Technological Advancements in In-Vito Fertilization (IVF) Process Fuels the Fertility Services Market Growth Opportunities

Recent advances in IVF technology are changing the landscape of fertility treatment. From genetic screening to time-lapse imaging of embryos to artificial intelligence and improved culture media, these innovations offer hope for couples struggling with infertility. These advances represent cutting-edge technologies and techniques transforming the field of in vitro fertilization, increasing success rates, and improving the overall patient experience.

AdvancementExplanation

Preimplantation Genetic Testing (PGT)PGT allows for the screening of embryos to identify genetic abnormalities before implantation, increasing the chances of a successful pregnancy by selecting healthy embryos.

Time-lapse Embryo ImagingContinuous monitoring of embryo development using time-lapse technology allows for better embryo selection based on growth patterns and milestones, improving IVF success rates.

Artificial Intelligence (AI) & Machine LearningAI and machine learning analyze patient data and embryonic development to provide personalized treatment recommendations, optimizing IVF outcomes.

Ovarian Tissue CryopreservationThis technology enables the freezing and preservation of ovarian tissue, containing viable eggs, for women undergoing cancer treatment or other medical procedures that affects fertility.

Improved Culture MediaAdvanced culture media formulations create an ideal environment for embryo development in the lab, leading to higher embryo quality and better IVF success rates.

Egg Freezing TechniquesVitrification, a rapid freezing method, has improved egg-freezing success rates, giving women more options for preserving their fertility.

Single Embryo Transfer (SET)Reducing the risk of multiple pregnancies, SET involves transferring a single carefully selected embryo, maintaining high success rates while minimizing complications.

Further, large companies operating in the fertility services market are developing new technologies to optimize IVF and thus gain a competitive advantage. In October 2022, a US-based medical device manufacturer, Alife Health, launched the Alife Assist platform, a range of products designed to revolutionize IVF by leveraging data-driven insights and artificial intelligence (AI). The platform helps in supporting clinical decision-making during key IVF phases and streamline fertility clinic operations. This innovative platform, consisting of Stim Assist, Embryo Assist, and Insights, provides comprehensive support to reproductive endocrinologists, embryologists, and clinic administrators to improve embryo grading, drug dosing, and real-time performance monitoring, ultimately improving patient experience and IVF success rates. Such advancements are expected to provide opportunities for the market growth in future.

Procedure -Based Insights

Based on procedure, the fertility services market is segmented into assisted reproductive technology, artificial insemination, and fertility surgeries. The assisted reproductive technology segment accounted for the largest market share in 2023. It is expected to register the highest CAGR during 2023-2031. The market for the assisted reproductive technology segment is further segmented into in vitro fertilization and intracytoplasmic sperm injection.

Patient Type -Based Insights

The fertility services market, based on patient type, is bifurcated into male and female. The female segment held a larger market share in 2023. However, the male segment is anticipated to register a higher CAGR during the forecast period.

End User -Based Insights

In terms of end user, the fertility services market is segmented into fertility centers, hospitals & surgical clinics, and others. The fertility centers segment held the largest market share in 2023 and is anticipated to register the highest CAGR during 2023-2031.

Leading players are implementing strategies such as expansion, partnership, launch of new products, and acquisition of a new customer base for tapping prevailing business opportunities.

In December 2022, Care Fertility Group expanded its global reach by entering into the US and Spain.

In November 2022, Mackay Specialist Day Hospital welcomed the opening of the new Virtus Rapid Access Endoscopy Clinic.

In October 2022, Indira IVF collaborated with Maven Clinic, a US-based company specializing in women's and family health with the help of telemedicine-based virtual clinics. The collaboration aimed to provide Maven members in India access to Indira IVF's high-quality clinical care, other benefits, and the best virtual family education care available through the Maven platform. Indira IVF is an India-based chain of specialty infertility clinics.

In August 2022, Genea Fertility was a Platinum Sponsor at the Australian Jewish Fertility Network's (AJFN) Annual Major Fundraiser.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the fertility services market report.

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Fertility Services Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Fertility Services Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Fertility Services Market - Global Market Analysis

6.1 Fertility Services - Global Market Overview
6.2 Fertility Services - Global Market and Forecast to 2031

7. Fertility Services Market - Revenue Analysis (USD Million) - By Procedure, 2021-2031

7.1 Overview
7.2 Assisted Reproductive Technology
- 7.2.1 In Vitro Fertilization (IVF)
- 7.2.2 Intracytoplasmic Sperm Injection
7.3 Artificial Insemination
- 7.3.1 Intrauterine Insemination
- 7.3.2 Intracervical Insemination
- 7.3.3 Intratubal Insemination
7.4 Fertility Surgeries

8. Fertility Services Market - Revenue Analysis (USD Million) - By Patient Type, 2021-2031

8.1 Overview
8.2 Male
8.3 Female

9. Fertility Services Market - Revenue Analysis (USD Million) - By End-User, 2021-2031

9.1 Overview
9.2 Fertility Clinics
9.3 Hospitals and Surgical Clinics
9.4 Others

10. Fertility Services Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

10.1 North America
- 10.1.1 North America Fertility Services Market Overview
- 10.1.2 North America Fertility Services Market Revenue and Forecasts to 2031
- 10.1.3 North America Fertility Services Market Revenue and Forecasts and Analysis - By Procedure
- 10.1.4 North America Fertility Services Market Revenue and Forecasts and Analysis - By Patient Type
- 10.1.5 North America Fertility Services Market Revenue and Forecasts and Analysis - By End-User
- 10.1.6 North America Fertility Services Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.7.1 United States Fertility Services Market
    - 10.1.7.1.1 United States Fertility Services Market, by Procedure
    - 10.1.7.1.2 United States Fertility Services Market, by Patient Type
    - 10.1.7.1.3 United States Fertility Services Market, by End-User
  - 10.1.7.2 Canada Fertility Services Market
    - 10.1.7.2.1 Canada Fertility Services Market, by Procedure
    - 10.1.7.2.2 Canada Fertility Services Market, by Patient Type
    - 10.1.7.2.3 Canada Fertility Services Market, by Donor Type
    - 10.1.7.2.3 Canada Fertility Services Market, by End-User
  - 10.1.7.3 Mexico Fertility Services Market
    - 10.1.7.3.1 Mexico Fertility Services Market, by Procedure
    - 10.1.7.3.2 Mexico Fertility Services Market, by Patient Type
    - 10.1.7.3.3 Mexico Fertility Services Market, by End-User

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East & Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East & Africa
10.5 South & Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South & Central America

11. Industry Landscape

11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration

13. Fertility Services Market - Key Company Profiles

13.1 CooperSurgical, Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments

Note - Similar information would be provided for below list of companies